Dexamethasone exacerbates cytotoxic chemotherapy induced lethargy and weight loss in female tumor free mice

References

• Aktas A, Walsh D, Rybicki L. Symptom clusters and prognosis in advanced cancer. Support Care Cancer. 2012;20(11):2837–43. doi:10.1007/s00520-012-1408-9.
   PubMed Web of Science ®Google Scholar
• Curt GA. The impact of fatigue on patients with cancer: Overview of FATIGUE 1 and 2. oncologist. 2000;5 Suppl 2:9–12. doi:10.1634/theoncologist.5-suppl_2-9.
   Google Scholar
• Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. oncologist. 2007;12 Suppl 1:4–10. doi:10.1634/theoncologist.12-S1-4.
   PubMed Web of Science ®Google Scholar
• Holmes D. Trying to unravel the mysteries of chemobrain. LancetNeurology. 2013;12(6):533–4.
   PubMedGoogle Scholar
• Myers JS, Pierce J, Pazdernik T. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncology nursing forum. 2008;35(6):916–20. doi:10.1188/08.ONF.916-920.
   PubMed Web of Science ®Google Scholar
• Thiagarajan M, Chan CM, Fuang HG, Beng TS, Atiliyana MA, Yahaya NA. Symptom Prevalence and Related Distress in Cancer Patients Undergoing Chemotherapy. Asian Pac J Cancer Prev. 2016;17(1):171–6. doi:10.7314/APJCP.2016.17.1.171.
   PubMedGoogle Scholar
• Berger AM, Gerber LH, Mayer DK. Cancer-related fatigue: implications for breast cancer survivors. Cancer. 2012;118(8 Suppl):2261–69. doi:10.1002/cncr.27475.
   PubMed Web of Science ®Google Scholar
• Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53. doi:10.1200/JCO.2000.18.4.743.
   PubMed Web of Science ®Google Scholar
• Cella D, Davis K, Breitbart W, Curt G, Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol. 2001;19(14):3385–91. doi:10.1200/JCO.2001.19.14.3385.
   PubMed Web of Science ®Google Scholar
• Luctkar-Flude MF, Groll DL, Tranmer JE, Woodend K. Fatigue and physical activity in older adults with cancer: A systematic review of the literature. Cancer Nurs. 2007;30(5):E35–45. doi:10.1097/01.NCC.0000290815.99323.75.
   PubMedGoogle Scholar
• Cheville AL. Cancer-related fatigue. Phys Med Rehabil Clin N Am. 2009;20(2):405–16. doi:10.1016/j.pmr.2008.12.005.
   PubMed Web of Science ®Google Scholar
• Radbruch L, Strasser F, Elsner F, Gonçalves JF, Løge J, Kaasa S, Nauck F, Stone P. Fatigue in palliative care patients – an EAPC approach. Palliat Med. 2008;22(1):13–32. doi:10.1177/0269216307085183.
   PubMed Web of Science ®Google Scholar
• Wood LJ, Weymann K. Inflammation and neural signaling: Etiologic mechanisms of the cancer treatment-related symptom cluster. Curr Opin Support Palliat Care. 2013;7(1):54–59. doi:10.1097/SPC.0b013e32835dabe3.
   PubMed Web of Science ®Google Scholar
• Braun TP, Szumowski M, Levasseur PR, Grossberg AJ, Zhu X, Agarwal A, Marks DL. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle. PLoS One. 2014;9(9):e106489. doi:10.1371/journal.pone.0106489.
   PubMed Web of Science ®Google Scholar
• Zhu W, Cao FS, Feng J, Chen HW, Wan JR, Lu Q, Wang J. NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide. Neuroscience. 2017;343:77–84. doi:10.1016/j.neuroscience.2016.11.037.
   PubMed Web of Science ®Google Scholar
• Grossberg AJ, Zhu X, Leinninger GM, Levasseur PR, Braun TP, Myers MG Jr, Marks DL. Inflammation-induced lethargy is mediated by suppression of orexin neuron activity. J Neurosci. 2011;31(31):11376–86. doi:10.1523/JNEUROSCI.2311-11.2011.
   PubMed Web of Science ®Google Scholar
• Smith LB, Leo MC, Anderson C, Wright TJ, Weymann KB, Wood LJ. The role of IL-1beta and TNF-alpha signaling in the genesis of cancer treatment related symptoms (CTRS): A study using cytokine receptor-deficient mice. Brain Behav Immun. 2014;38:66–76. doi:10.1016/j.bbi.2013.12.022.
   PubMed Web of Science ®Google Scholar
• Weymann KB, Wood LJ, Zhu X, Marks DL. A role for orexin in cytotoxic chemotherapy-induced fatigue. Brain Behav Immun. 2014;37:84–94. doi:10.1016/j.bbi.2013.11.003.
   PubMed Web of Science ®Google Scholar
• McDonald TL, Hung AY, Thomas CR, Wood LJ. Localized External Beam Radiation Therapy (EBRT) to the Pelvis Induces Systemic IL-1Beta and TNF-Alpha Production: Role of the TNF-Alpha Signaling in EBRT-Induced Fatigue. Radiat Res. 2016;185(1):4–12. doi:10.1667/RR14072.1.
   PubMed Web of Science ®Google Scholar
• Bower JE. Cancer-related fatigue–mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597–609. doi:10.1038/nrclinonc.2014.127.
   PubMed Web of Science ®Google Scholar
• Kruse JL, Strouse TB. Sick and tired: Mood, fatigue, and inflammation in cancer. Curr Psychiatry Rep. 2015;17(3):555. doi:10.1007/s11920-015-0555-3.
   PubMed Web of Science ®Google Scholar
• Floman Y, Zor U. Mechanism of steroid action in inflammation: Inhibition of prostaglandin synthesis and release. Prostaglandins. 1976;12(3):403–413. doi:10.1016/0090-6980(76)90021-6.
   PubMedGoogle Scholar
• Yamasaki H, Yamamoto T. Inhibitory Effect of Adrenal Glucocorticoids on Histamine Release. Jpn J Pharmacol. 1963;13:223–4. doi:10.1254/jjp.13.223.
   PubMedGoogle Scholar
• Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J Leukoc Biol. 1996;60(5):563–572.
   PubMed Web of Science ®Google Scholar
• Piccolella E, Lombardi G, Vismara D, Del Gallo F, Colizzi V, Dolei A, Dianzani F. Effects of dexamethasone on human natural killer cell cytotoxicity, interferon production, and interleukin-2 receptor expression induced by microbial antigens. Infect Immun. 1986;51(2):712–14.
   PubMed Web of Science ®Google Scholar
• Wahl SM, Altman LC, Rosenstreich DL. Inhibition of in vitro lymphokine synthesis by glucocorticosteroids. Journal of immunology (Baltimore, Md: 1950). 1975;115(2):476–481.
   PubMed Web of Science ®Google Scholar
• Xu T, Qiao J, Zhao L, He G, Li K, Wang J, Tian Y, Wang H. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J. 2009;33(4):852–60. doi:10.1183/09031936.00130507.
   PubMed Web of Science ®Google Scholar
• Wen SH, Wu HJ, Lin L, Chong L, Zhu LL, Zhang WX, Zhang HL, Li CC. Adjunctive dexamethasone therapy improves lung injury by inhibiting inflammation and reducing RIP3 expression during Staphylococcus aureus pneumonia in mice. Int Immunopharmacol. 2014;23(2):709–18. doi:10.1016/j.intimp.2014.10.027.
   PubMed Web of Science ®Google Scholar
• Rocksen D, Lilliehook B, Larsson R, Johansson T, Bucht A. Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol. 2000;122(2):249–56. doi:10.1046/j.1365-2249.2000.01373.x.
   PubMed Web of Science ®Google Scholar
• Bersani-Amado LE, Dantas JA, Damiao MJ, Rocha BA, Besson JC, Bastos RL, Silva LN, Bersani-Amado CA, Cuman RK. Involvement of cytokines in the modulation and progression of renal fibrosis induced by unilateral ureteral obstruction in C57BL/6 mice: Effects of thalidomide and dexamethasone. Fundam Clin Pharmacol. 2016;30(1):35–46. doi:10.1111/fcp.12162.
   PubMed Web of Science ®Google Scholar
• Ettinger DS, Bierman PJ, Bradbury B, Comish CC, Ellis G, Ignoffo RJ, Kirkegaard S, Kloth DD, Kris MG, Lim D, et al. Antiemesis. J Natl Compr Canc Netw. 2007;5(1):12–33. doi:10.6004/jnccn.2007.0004.
   PubMedGoogle Scholar
• Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, et al. Reduction of cancer-related fatigue with dexamethasone: A double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076–82. doi:10.1200/JCO.2012.44.4661.
   PubMed Web of Science ®Google Scholar
• Vardy J, Chiew KS, Galica J, Pond GR, Tannock IF. Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer. 2006;94(7):1011–15. doi:10.1038/sj.bjc.6603048.
   PubMed Web of Science ®Google Scholar
• Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009;27(31):5233–39. doi:10.1200/JCO.2008.21.6333.
   PubMed Web of Science ®Google Scholar
• Savard J, Liu L, Natarajan L, Rissling MB, Neikrug AB, He F, Dimsdale JE, Mills PJ, Parker BA, Sadler GR, et al. Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009;32(9):1155–60. doi:10.1093/sleep/32.9.1155.
   PubMed Web of Science ®Google Scholar
• Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010;28(2):292–98. doi:10.1200/JCO.2009.22.5011.
   PubMed Web of Science ®Google Scholar
• Minton O, Stone PC. A comparison of cognitive function, sleep and activity levels in disease-free breast cancer patients with or without cancer-related fatigue syndrome. BMJ Support Palliat Care. 2012;2(3):231–38. doi:10.1136/bmjspcare-2011-000172.
   PubMedGoogle Scholar
• Minton O, Alexander S, Stone PC. Identification of factors associated with cancer related fatigue syndrome in disease-free breast cancer patients after completing primary treatment. Breast Cancer Res Treat. 2012;136(2):513–20. doi:10.1007/s10549-012-2284-1.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Furlow JD. Glucocorticoids and Skeletal Muscle. Adv Exp Med Biol. 2015;872:145–76. doi:10.1007/978-1-4939-2895-8_7.
   PubMed Web of Science ®Google Scholar
• Eriksson S, Nilsson JH, Strandberg Holka P, Eberhard J, Keussen I, Sturesson C. The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases. HPB (Oxford). 2017;19(4):331–37. doi:10.1016/j.hpb.2016.11.009.
   Web of Science ®Google Scholar
• Rutten IJ, van Dijk DP, Kruitwagen RF, Beets-Tan RG, Olde Damink SW, van Gorp T. Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. J Cachexia Sarcopenia Muscle. 2016;7(4):458–66. doi:10.1002/jcsm.12107.
   PubMed Web of Science ®Google Scholar
• Reisinger KW, Bosmans JW, Uittenbogaart M, Alsoumali A, Poeze M, Sosef MN, Derikx JP. Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery. Ann Surg Oncol. 2015;22(13):4445–52. doi:10.1245/s10434-015-4558-4.
   PubMed Web of Science ®Google Scholar
• Takayoshi K, Uchino K, Nakano M, Ikejiri K, Baba E. Weight Loss During Initial Chemotherapy Predicts Survival in Patients With Advanced Gastric Cancer. Nutr Cancer. 2017;69(3):408–15. doi:10.1080/01635581.2017.1267774.
   PubMed Web of Science ®Google Scholar
• Ullman-Cullere MH, Foltz CJ. Body condition scoring: a rapid and accurate method for assessing health status in mice. Lab Anim Sci. 1999;49(3):319–23.
   PubMedGoogle Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–61. doi:10.1096/fj.07-9574LSF.
   PubMed Web of Science ®Google Scholar
• de Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res. 2010;215(1):146–51. doi:10.1016/j.bbr.2010.07.015.
   PubMed Web of Science ®Google Scholar
• Hanaa-Mansour A , Hassan WA, Georgy GS. Dexamethazone protects against Escherichia coli induced sickness behavior in rats. Brain Res. 2016;1630:198–207. doi:10.1016/j.brainres.2015.10.049.
   PubMed Web of Science ®Google Scholar
• Terada K, Izumo N, Suzuki B, Karube Y, Morikawa T, Ishibashi Y, Kameyama T, Chiba K, Sasaki N, Iwata K. Fluvoxamine moderates reduced voluntary activity following chronic dexamethasone infusion in mice via recovery of BDNF signal cascades. Neurochem Int. 2014;69:9–13. doi:10.1016/j.neuint.2014.02.002.
   PubMed Web of Science ®Google Scholar
• Sigwalt AR, Budde H, Helmich I, Glaser V, Ghisoni K, Lanza S, Cadore EL, Lhullier FL, de Bem AF, Hohl A, et al. Molecular aspects involved in swimming exercise training reducing anhedonia in a rat model of depression. Neuroscience. 2011;192:661–74. doi:10.1016/j.neuroscience.2011.05.075.
   PubMed Web of Science ®Google Scholar
• Casarotto PC, Andreatini R. Repeated paroxetine treatment reverses anhedonia induced in rats by chronic mild stress or dexamethasone. Eur Neuropsychopharmacol. 2007;17(11):735–42. doi:10.1016/j.euroneuro.2007.03.001.
   PubMed Web of Science ®Google Scholar
• Foltran RB, Diaz SL. BDNF isoforms: A round trip ticket between neurogenesis and serotonin? J Neurochem. 2016;138(2):204–21. doi:10.1111/jnc.13658.
   PubMed Web of Science ®Google Scholar
• Kempermann G, Song H, Gage FH. Neurogenesis in the Adult Hippocampus. Cold Spring Harb Perspect Biol. 2015;7(9):a018812. doi:10.1101/cshperspect.a018812.
   PubMed Web of Science ®Google Scholar
• Ruksee N, Tongjaroenbuangam W, Mahanam T, Govitrapong P. Melatonin pretreatment prevented the effect of dexamethasone negative alterations on behavior and hippocampal neurogenesis in the mouse brain. J Steroid Biochem Mol Biol. 2014;143:72–80. doi:10.1016/j.jsbmb.2014.02.011.
   PubMed Web of Science ®Google Scholar
• Kim JB, Ju JY, Kim JH, Kim TY, Yang BH, Lee YS, Son H. Dexamethasone inhibits proliferation of adult hippocampal neurogenesis in vivo and in vitro. Brain Res. 2004;1027(1-2):1–10. doi:10.1016/j.brainres.2004.07.093.
   PubMed Web of Science ®Google Scholar
• Bjorkholm C, Monteggia LM. BDNF – a key transducer of antidepressant effects. Neuropharmacology. 2016;102:72–79. doi:10.1016/j.neuropharm.2015.10.034.
   PubMed Web of Science ®Google Scholar
• Elsea CR, Kneiss JA, Wood LJ. Induction of IL-6 by Cytotoxic Chemotherapy Is Associated With Loss of Lean Body and Fat Mass in Tumor-free Female Mice. Biological research for nursing. 2015;17(5):549–57. doi:10.1177/1099800414558087.
   PubMed Web of Science ®Google Scholar